Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

We have observed 8 EP applications Jianping Zhuang Plodeck has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12746320

COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE

IPC classification:
A61K 31/553, A61K 31/554, A61P 11/00, A61P 31/12, C07D 403/04, C07D 413/04, C07D 417/04, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Jianping Zhuang Plodeck, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12772299

COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE

IPC classification:
A61K 31/519, A61P 31/12, C07D 495/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Jianping Zhuang Plodeck, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13705187

ANTIVIRAL COMPOUNDS

IPC classification:
A61K 31/401, A61K 31/422, A61K 31/423, A61K 31/4468, A61K 31/4709, A61P 31/12, C07D 207/16, C07D 211/60, C07D 401/12, C07D 413/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Jianping Zhuang Plodeck, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12726438

METHOD OF TREATING DENGUE FEVER

IPC classification:
A61K 31/7068, A61K 31/7072, A61K 31/7076, A61K 31/708, A61P 31/12, C07H 19/10, C07H 19/20
Applicant:
F. Hoffmann-La Roche AG
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Jianping Zhuang Plodeck, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13712263

NOVEL 4-METHYL-DIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

IPC classification:
A61K 31/506, A61P 31/12, C07D 401/14, C07D 403/14, C07D 409/14, C07D 413/14, C07D 417/04, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Jianping Zhuang Plodeck, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13735011

NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION

IPC classification:
A61K 31/46, A61P 31/12, C07D 403/06, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Jianping Zhuang Plodeck, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13750699

NOVEL PHENYL-PYRIDINE/PYRAZINE AMIDES FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/4418, A61K 31/4436, A61K 31/444, A61K 31/4965, A61P 35/00, C07D 213/74, C07D 213/81, C07D 241/20, C07D 409/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Jianping Zhuang Plodeck, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13763201

6-AMINO ACID HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

IPC classification:
A61K 31/506, A61K 31/5355, A61P 31/20, C07D 401/14, C07D 403/06, C07D 409/14, C07D 413/14, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Jianping Zhuang Plodeck, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED

Please Sign in to use this feature